Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 329 Records) |
| Query Trace: Carcinoma and BRCA2[original query] |
|---|
| Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways. International journal of cancer 2024 9 . Carolina Pires, Inês J Marques, Ana Saramago, Margarida M Moura, Marta Pojo, Rafael Cabrera, Catarina Santos, Francisco Rosário, Diana Lousa, João B Vicente, Tiago M Bandeiras, Manuel R Teixeira, Valeriano Leite, Branca M Cava |
| Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1-Associated Genes in Finnish Patients with Uveal Melanoma. Pigment cell & melanoma research 2024 9 . Pauliina E Repo, Eveliina Jakkula, Juho Hiltunen, Heidi Putkuri, Aleksandra Staskiewicz-Tuikkanen, Reetta-Stiina Järvinen, Martin Täll, Virpi Raivio, Rana'a T Al-Jamal, Tero T Kivelä, Joni A Turun |
| The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer. Annals of surgical oncology 2024 9 . Mahtab Vasigh, Ahmed Mohamed, Lisa Jacobs, Julie Lange, Melissa Camp, Bonnie Sun, Pamela Wright, Maureen O'Donnell, Hanh-Tam Tran, Olutayo Sogunro, Mehran Habibi, Fabian Johnston, David Euh |
| Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type. Frontiers in oncology 2024 9 14 1412807. Roberto Buonaiuto, Giuseppe Neola, Aldo Caltavituro, Alessandra Longobardi, Federica Pia Mangiacotti, Amedeo Cefaliello, Maria Rosaria Lamia, Francesco Pepe, Jole Ventriglia, Umberto Malapelle, Giancarlo Troncone, Mario Giuliano, Grazia Arpino, Sandro Pignata, Carmine De Angel |
| Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients. Gynecologic oncology reports 2024 9 55 101498. Katelyn Tondo-Steele, Kara J Milliron, Jean H Siedel, Shitanshu Uppal, Sofia D Merajver, Karen McLe |
| [Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 8 53 (8): 789-796. D H Wang, W L Yin, X Y Pan, M N Zhang, L Nie, X Q Chen, H Zeng, Q Zhou, N Ch |
| The Pathological Pattern of Breast Cancer in the Najran Region of Saudi Arabia: A Retrospective Study. Cureus 2024 8 16 (8): e67621. Abdulrahman M Alamri, Hajar H AlWadai, Saad M Almowallad, Saleh M AlKulayb, Zahra E Abdalwahab, Shuruq M Alzahuf, Saleh H Alshaib |
| General analysis of breast cancer patients tested for BRCA mutations and evaluation of acute radiotherapy toxicity. Northern clinics of Istanbul 2024 8 11 (4): 302-308. Sule Karabulut Gul, Huseyin Tepetam, Berrin Benli Yavuz, Ozge Kandemir Gursel, Ayse Altinok, Irem Yuksel, Omar Alomari, Banu Atalar, Ilknur Bilkay Gork |
| Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations. Gynecologic oncology 2024 8 190 18-27. Xin Ray Tee, Emma Hazard, Elena Latorre-Esteves, Brendan F Kohrn, Talayeh S Ghezelayagh, Jeanne Uy Fredrickson, CoohleenAnn Coombes, Marc R Radke, Enna Manhardt, Ronit Katz, T Rinda Soong, Elizabeth M Swisher, Barbara M Norquist, Rosa Ana Risqu |
| Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening. JCO precision oncology 2024 8 8 e2400094. Kate I Glennon, Mikiko Endo, Yoshiaki Usui, Yusuke Iwasaki, Rodney H Breau, Anil Kapoor, Mark Lathrop, Simon Tanguay, Yukihide Momozawa, Yasser Riazalhossei |
| Integrative genomic analysis reveals cancer-associated mutations in patients with ophthalmic tumors. The Journal of international medical research 2024 7 52 (7): 3000605241258171. Fengjiao Zhu, Pengpeng Wang, Zhiyuan Zhang, Chunlei Yao, Yijie Wang, Juan Ye, Jian |
| The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. Journal of gynecologic oncology 2024 7 . Yeon Jee Lee, Ji Hyun Kim, Youn Jee Kim, Yoon Jung Chang, Sun-Young Kong, Chong Woo Yoo, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol L |
| Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 6 . Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A Zwimpfer, Nicola S Meagher, Sian Fereday, Laura Twomey, Kathleen I Pishas, Therese Hoang, Adelyn Bolithon, Nadia Traficante, Kathryn Alsop, Elizabeth L Christie, Eun-Young Kang, Gregg S Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J Riggan, Jennifer Alsop, Matthias W Beckmann, Jessica Boros, Alison H Brand, Angela Brooks-Wilson, Michael E Carney, Penny Coulson, Madeleine Courtney-Brooks, Kara L Cushing-Haugen, Cezary Cybulski, Mona El-Bahrawy, Esther Elishaev, Ramona Erber, Simon A Gayther, Aleksandra Gentry-Maharaj, C Blake Gilks, Paul R Harnett, Holly R Harris, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y Hernandez, Anna Jakubowska, Mercedes Jimenez-Linan, Michael E Jones, Scott H Kaufmann, Catherine J Kennedy, Tomasz Kluz, Jennifer M Koziak, Björg Kristjansdottir, Nhu D Le, Marcin Lener, Jenny Lester, Jan Lubi?ski, Constantina Mateoiu, Sandra Orsulic, Matthias Ruebner, Minouk J Schoemaker, Mitul Shah, Raghwa Sharma, Mark E Sherman, Yurii B Shvetsov, T Rinda Soong, Helen Steed, Paniti Sukumvanich, Aline Talhouk, Sarah E Taylor, Robert A Vierkant, Chen Wang, Martin Widschwendter, Lynne R Wilkens, Stacey J Winham, Michael S Anglesio, Andrew Berchuck, James D Brenton, Ian Campbell, Linda S Cook, Jennifer A Doherty, Peter A Fasching, Renée Turzanski Fortner, Marc T Goodman, Jacek Gronwald, David G Huntsman, Beth Y Karlan, Linda E Kelemen, Usha Menon, Francesmary Modugno, Paul D P Pharoah, Joellen M Schildkraut, Karin Sundfeldt, Anthony J Swerdlow, Ellen L Goode, Anna DeFazio, Martin Köbel, Susan J Ramus, David D L Bowtell, Dale W Gars |
| Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China. Journal of cancer research and clinical oncology 2024 6 150 (6): 322. Jing Li, Peng He, Qindong Cai, Lili Chen, Yali Wang, Weifeng Cai, Yibin Qiu, Shunyi Liu, Wenhui Guo, Minyan Chen, Yuxiang Lin, Chuan Wang, Fangmeng |
| Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice. BMC cancer 2024 6 24 (1): 673. Mengqi Song, Haoyue Cheng, Hao Zou, Kai Ma, Lianfang Lu, Qian Wei, Zejiang Xu, Zirui Tang, Yuanzheng Zhang, Yinan Wang, Chuandong S |
| The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. Familial cancer 2024 5 . Hiroyuki Matsubayashi, Akiko Todaka, Takahiro Tsushima, Yoshimi Kiyozumi, Rina Harada, Eiko Ishihara, Satomi Higashigawa, Nobuyuki Ohike, Hiroki Sakamoto, Junya Sato, Hirotoshi Ishiwatari, Teichi Sugiura, Katsuhiko Uesa |
| A chromosome-scale fishing cat reference genome for the evaluation of potential germline risk variants. Scientific reports 2024 4 14 (1): 8073. Rachel A Carroll, Edward S Rice, William J Murphy, Leslie A Lyons, Francoise Thibaud-Nissen, Lyndon M Coghill, William F Swanson, Karen A Terio, Tyler Boyd, Wesley C Warr |
| BRCA2 germline mutation carrier with five malignancies: a case report. Hereditary cancer in clinical practice 2024 12 22 (1): 27. Elena Su, Yann Christinat, Thomas McKee, Silvia Azzarello-Burri, Wolfram Jochum, Stefanie Fischer, Christian Rothermun |
| Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohort. ESMO open 2024 12 10 (1): 104090. F Camarda, L Mastrantoni, C Parrillo, A Minucci, F Persiani, D Giannarelli, T Pasciuto, F Giacomini, E De Paolis, M Manfredelli, C Marchetti, G F Zannoni, A Fagotti, G Scambia, C Ne |
| Prognostic implications of ductal carcinoma in situ components in BRCA1/2-positive breast cancer: a retrospective cohort study. Annals of surgical treatment and research 2024 12 107 (6): 327-335. Kyung-Hwak Yoon, Eun-Kyu Kim, Hee-Chul Sh |
| Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites. medRxiv : the preprint server for health sciences 2024 11 . E Ebrahimi, A Sangphukieo, H A Park, V Gaborieau, A Ferreiro-Iglesias, B Diergaarde, W Ahrens, L Alemany, Lmrb Arantes, J Betka, S V Bratman, C Canova, Msc Conlon, D I Conway, M Cuello, M Curado, A de Carvalho, J de Oliviera, M Gormley, M Hadji, S Hargreaves, C M Healy, I Holcatova, R J Hung, L P Kowalski, P Lagiou, A Lagiou, G Liu, G J Macfarlane, A F Olshan, S Perdomo, L F Pinto, J V Podesta, J Polesel, M Pring, H Rashidian, R R Gama, L Richiardi, M Robinson, P A Rodriguez-Urrego, S A Santi, D P Saunders, S C Soares-Lima, N Timpson, M Vilensky, S V von Zeidler, T Waterboer, K Zendehdel, A Znaor, P Brennan, , J McKay, S Virani, T Duddi |
| Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma. Annals of surgical oncology 2024 11 . Alex B Blair, Shannon N Radomski, Joanne Chou, Mengyuan Liu, Thomas Clark Howell, Wungki Park, Eileen M O'Reilly, Lei Zheng, Vinod P Balachandran, Alice C Wei, T Peter Kingham, Michael I D'Angelica, Jeffrey Drebin, Sabino Zani, Dan G Blazer, Richard A Burkhart, William R Burns, Kelly J Lafaro, Peter J Allen, William R Jarnagin, Michael E Lidsky, Jin He, Kevin C Soar |
| High Rates of Germline Pathogenic Variants in Somali Patients with Ovarian Cancer. Gynecologic oncology reports 2024 11 56 101538. José V Somohano-Short, Natasha Crawford, Mahmoud A Khalifa, Britt K Ericks |
| BRCA2 mutations in familial breast cancer with prostate cancer: a case report and literature review. Frontiers in oncology 2024 10 14 1428849. Zhengsheng Liu, Qianhao Huang, Meixuan Ding, Tao Wang, Yuedong Chen, Kaiyan Zha |
| Clinicopathogenomic analysis of PI3K/AKT/PTEN-altered luminal metastatic breast cancer in Japan. Breast cancer (Tokyo, Japan) 2024 10 . Hiroshi Tada, Minoru Miyashita, Narumi Harada-Shoji, Akiko Ebata, Miku Sato, Tokiwa Motonari, Mika Yanagaki, Tomomi Kon, Aru Sakamoto, Takanori Ishi |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
| Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Human pathology 2024 1 . Jon Mahlow, Marc Barry, Daniel J Albertson, Yeon Jung Jo, Michael Balatico, Tori Seasor, Georges Gebrael, Shruti A Kumar, Nicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, Umang Swami, Deepika Siro |
| BRCA mutation status and pathological characterization of breast cancer in Zhoushan Islands, China. The Journal of international medical research 2024 1 52 (1): 3000605231223426. Shuhui Bao, Nini Sun, Yaling Li, Jiaojie Shu, Jing Xu, Yong Zhang, Xia Q |
| GERMLINE PATHOGENIC VARIANTS IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA AND EXTRA-PANCREATIC MALIGNANCIES: A NATIONWIDE DATABASE ANALYSIS. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2025 1 100709. Valentyna Kryklyva, Michael J Pflüger, Hicham Ouchene, Hanneke Volleberg-Gorissen, Arjen R Mensenkamp, Marianne A Jonker, Carlijn van de Water, Iris D Nagtegaal, Marjolijn J L Ligtenberg, Lodewijk A A Brose |
| Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing. NPJ genomic medicine 2025 1 10 (1): 1. Deepak N Subramanian, Maia Zethoven, Kathleen I Pishas, Evanny R Marinovi?, Simone McInerny, Simone M Rowley, Prue E Allan, Lisa Devereux, Dane Cheasley, Paul A James, Ian G Campbe |
- Page last reviewed:Feb 1, 2024
- Content source: